Real-world Comparative Effectiveness of Palbociclib Plus Aromatase Inhibitor in HR+/HER2− Metastatic Breast Cancer - Supplementary material
收藏DataCite Commons2024-05-15 更新2025-04-15 收录
下载链接：
https://tandf.figshare.com/articles/dataset/Real-world_Comparative_Effectiveness_of_Palbociclib_Plus_Aromatase_Inhibitor_in_HR_HER2_Metastatic_Breast_Cancer_-_Supplementary_material/25013042/1
下载链接
链接失效反馈官方服务：
资源简介：
Table S1. Definitions of real-world tumor response.Table S2. Summary of study treatments (unadjusted population).Table S3. Reasons for discontinuing first-line treatment (unadjusted population).Table S4. Reason for censoring in OS and rwPFS analyses (nIPTW-adjusted population)Figure S1. Forest plot of overall survival by subgroup after PSMFigure S2. Forest plot for real-world progression-free survival by subgroup after PSM.
表S1. 真实世界肿瘤应答定义（real-world tumor response）
表S2. 研究治疗总结（未校正人群，unadjusted population）
表S3. 一线治疗终止原因（未校正人群，unadjusted population）
表S4. 总生存期（Overall Survival, OS）和真实世界无进展生存期（real-world Progression-Free Survival, rwPFS）分析中的删失原因（nIPTW校正人群，nIPTW-adjusted population）
图S1. 倾向评分匹配（Propensity Score Matching, PSM）后各亚组总生存期的森林图（Forest plot）
图S2. 倾向评分匹配（Propensity Score Matching, PSM）后各亚组真实世界无进展生存期的森林图（Forest plot）
提供机构：
Taylor & Francis
创建时间：
2024-01-17
